Sinus Dilation Devices Market Size By Product (Balloon Sinus Dilation Devices, Sinus Implants, Handheld Instruments, Sinuscopes, Rhinoscopes), By Procedure (Standalone Sinus Dilation Procedures, Hybrid Sinus Dilation Procedures), By End-use (Hospital, Physicians Office, Ambulatory Surgical Centers), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Marke
Published on: 2024-08-03 | No of Pages : 240 | Industry : Healthcare
Publisher : MIR | Format : PDF&Excel
Sinus Dilation Devices Market Size By Product (Balloon Sinus Dilation Devices, Sinus Implants, Handheld Instruments, Sinuscopes, Rhinoscopes), By Procedure (Standalone Sinus Dilation Procedures, Hybrid Sinus Dilation Procedures), By End-use (Hospital, Physicians Office, Ambulatory Surgical Centers), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Marke
Sinus Dilation Devices Market Size
Sinus Dilation Devices Market size valued at around USD 1.8 billion in 2019 and is projected to grow at a CAGR of 9.1% between 2020 and 2026. Growing cases of chronic sinusitis offer high growth opportunities to the players operating in the market. Lifestyle changes increase in comorbid diseases and environmental factors are some of the attributes surging the sinusitis cases. Advantages associated with minimally invasive procedures such as reduction in blood loss, less recovery time and shorter hospital stays will boost the sinus dilation devices demand.
The ongoing COVID-19 pandemic has slightly affected the sinus dilation devices industry, as the surgeons around the world have delayed the minimally invasive surgeries required for sinusitis. During this pandemic, elective surgeries have been cancelled or postponed decreasing the risk of patients being exposed to COVID-19 in hospital, thereby supporting the hospitals in converting operating theatres into intensive care units.
Report Attribute | Details |
---|---|
Base Year | 2019 |
Sinus Dilation Devices Market Size in 2019 | USD 1.8 Billion |
Forecast Period | 2020 to 2026 |
Forecast Period 2020 to 2026 CAGR | 9.1% |
2026 Value Projection | USD 3.3 Billion |
Historical Data for | 2015 to 2019 |
No. of Pages | 125 |
Tables, Charts & Figures | 180 |
Segments covered | Product, Procedure, End-use |
Growth Drivers |
|
Pitfalls & Challenges |
|
Upsurge in demand for more specific and effective technologies for sinusitis treatment is one of the key factors driving the market growth. Growing focus of market leaders on new product development and product upgradation will influence the industry expansion. Furthermore, increasing adoption of minimally invasive procedures in developed as well as developing economies will serve to be an impact rendering factor in the market.
Growing demand for handheld instruments will drive the sinus dilation devices market share
Handheld instruments segment valuation was more than USD 379 million in 2019. Handheld instruments are utilized as visualization aid and support during the sinus dilation procedures that enhances the surgical performance. Increasing number of sinusitis cases across the globe and rise in healthcare spending on sinus dilation procedures will augment the demand for handheld instruments.
Sinus Dilation Devices Market Analysis
Hybrid sinus dilation procedures segment in the sinus dilation devices market is anticipated to witness 9.2% growth rate till 2026. Hybrid sinus dilation procedure is a combination of standalone sinus dilation with functional endoscopic sinus surgery (FESS). Availability of superior quality sinus dilation devices, implants and other instruments will facilitate the performance of hybrid sinus dilation procedures. These attributes have enhanced the success rate of hybrid sinus dilation procedures that will in turn impact its preference amongst the doctors and physicians.
Physician’s office end-use segment is estimated to attain a CAGR of over 10% through 2026 owing to the rising number of sinus dilation procedures conducted at physician’s office. The procedures are carried out in a single day at physician’s office that enables faster patient recovery. Patients with chronic rhinosinusitis often prefer receiving treatment at the physician’s office.
For instance, facility-based hybrid endoscopic sinus surgery (ESS) procedures are performed efficiently and patients can resume their daily activities in shorter period of time. Hence, these attributes have boosted the number of sinus dilation procedures taking place at physician’s office. In addition, population with low income prefer receiving treatments at the physician’s office as they offer sinus dilation treatment at relatively lower costs compared to the hospitals.
U.S. dominated the North America sinus dilation devices market with USD 564 million revenue in 2019 driven by the presence of state-of-the-art healthcare facilities and large patient population suffering from chronic sinusitis in the country. Strong foothold of key industry players coupled with high adoption of new technologies will augment the market expansion. Favorable reimbursement scenario will increase the adoption rate of sinus procedures among the patient population.
Japan market size crossed USD 145 million in 2019 impelled by increasing prevalence of acute as well as chronic sinusitis in the country. Climate and humidity factors are also noted as prime reasons for sinus diseases. Growing awareness regarding minimally invasive procedures for treatment as well as improving healthcare facilities will accelerate the market statistics.
Sinus Dilation Devices Market Share
Some of the major companies operational in the sinus dilation devices market are
- dalENT Medical
- Jilin Coronado Medical
- Entellus Medical
- InAccel
- Acclarent
- Creganna Medical
- Intersect ENT
- Medtronic
- Meril Life Sciences
- SinuSys Corporation
- Olympus Corporation
These industry participants have implemented certain strategic initiatives such as collaborations, acquisitions and product launches that have enhanced their financial stability and helped them evolve as major industry players.
Recent industry developments
- In February 2018, Stryker acquired Entellus Medical that manufactures products designed for minimally invasive treatment of various ear, nose and throat (ENT) diseases to diversify existing product portfolio.
- In December 2018, Intersect ENT announced its first patient in company’s study of new product platform, the ASCEND investigational drug coated sinus balloon. This combination helped the company in gaining revenue in localized drug delivery.
This market research report on sinus dilation devices includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2015 to 2026, for the following segments
Click here to Buy Section of this Report
Market, By Product
- Balloon Sinus Dilation Devices
- Sinus Implants
- Handheld Instruments
- Sinuscopes
- Rhinoscopes
Market, By Procedure
- Standalone Sinus Dilation Procedures
- Hybrid Sinus Dilation Procedures
Market, By End-use
- Hospital
- Physician's Office
- Ambulatory Surgical Centres
- Others
The above information is provided for the following regions and countries
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Asia Pacific
- China
- India
- Japan
- Latin America
- Brazil
- Mexico
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE